BioMarin Pharmaceutical Inc. (BMRN)

NASDAQ: BMRN · IEX Real-Time Price · USD

82.22

+0.09 (0.11%)

At close: Jul 2, 2024, 4:00 PM

82.00

-0.22 (-0.27%)

After-hours: Jul 2, 2024, 5:16 PM EDT

BioMarin Pharmaceutical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1996
Net Income	167.65	141.56	-64.08	854.03	-23.85	Upgrade
Depreciation & Amortization	104.39	101.97	108.04	105.17	105.3	Upgrade
Share-Based Compensation	207.1	196.31	197.26	189.71	159.87	Upgrade
Other Operating Activities	-319.87	-263.94	63.31	-1,063.55	-193.06	Upgrade
Operating Cash Flow	159.26	175.9	304.54	85.37	48.26	Upgrade
Operating Cash Flow Growth	-9.46%	-42.24%	256.75%	76.88%	138.83%	Upgrade
Capital Expenditures	-96.69	-17.63	-95.58	-47.15	-120.03	Upgrade
Change in Investments	-3.63	8.19	-246.09	17.46	108.19	Upgrade
Other Investing Activities	-10.92	-10.58	-24.64	-23.93	-19.19	Upgrade
Investing Cash Flow	-111.24	-20.03	-366.31	-53.62	-31.03	Upgrade
Share Issuance / Repurchase	69.35	69.33	49.19	21.91	31.61	Upgrade
Debt Issued / Paid	-2.29	-2.61	-3.04	203.84	-5.09	Upgrade
Other Financing Activities	-85.79	-85.38	-46.2	-44.64	-101.2	Upgrade
Financing Cash Flow	-18.73	-18.65	-0.05	181.12	-74.67	Upgrade
Exchange Rate Effect	1.31	0.03	-0.06	-1.15	0.9	Upgrade
Net Cash Flow	30.6	137.26	-61.88	211.71	-56.54	Upgrade
Free Cash Flow	62.57	158.27	208.96	38.21	-71.76	Upgrade
Free Cash Flow Growth	-60.47%	-24.26%	446.84%	-	-	Upgrade
Free Cash Flow Margin	2.59%	7.55%	11.32%	2.05%	-4.21%	Upgrade
Free Cash Flow Per Share	0.33	0.85	1.14	0.21	-0.40	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).